Recruitment

Recruitment Status
Completed
Estimated Enrollment
16

Summary

Conditions
Hepatitis C
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 65 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01537900
Collaborators
Not Provided
Investigators
Study Director: Medical Director Merck Sharp & Dohme Corp.